Tissue-specific transformation by epidermal growth factor receptor

A single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential

H. K.G. Shu, R. J. Pelley, H. J. Kung

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Avian c-erbB is activated to a leukemia oncogene following truncation of its amino-terminal, ligand-binding domain by retroviral insertion. The insertionally activated transcripts encode protein products that have constitutive tyrosine kinase activity and that can induce erythroleukemia but not sarcomas. We have found that a single point mutation within the ATP-binding pocket of the tyrosine kinase domain in this truncated molecule can increase the ability of this oncogene to induce anchorage-independent growth of fibroblasts in vitro and fibrosarcoma formation in vivo. Associated with this increased transforming potential is a corresponding increase in the kinase activity of the mutant erbB protein product. The mutation, which converts a valine to isoleucine at position 157 of the insertionally activated c-erbB product, is at a residue that is highly conserved within the protein kinase family. To our knowledge, this is the first demonstration of a point mutation in the ATP-binding pocket that activates a tyrosine kinase.

Original languageEnglish
Pages (from-to)9103-9107
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume87
Issue number23
DOIs
Publication statusPublished - Dec 1 1990
Externally publishedYes

Fingerprint

Point Mutation
Epidermal Growth Factor Receptor
Protein-Tyrosine Kinases
Phosphotransferases
Adenosine Triphosphate
Oncogenes
Leukemia, Erythroblastic, Acute
Isoleucine
Fibrosarcoma
Valine
Mutant Proteins
Sarcoma
Protein Kinases
Leukemia
Fibroblasts
Ligands
Mutation
Growth
Proteins

Keywords

  • cellular transformation
  • erythroblastosis
  • retrovirus
  • sarcoma
  • tyrosine kinase

ASJC Scopus subject areas

  • General

Cite this

@article{92a10a01fdaf40dbb63ea59a5c2fab74,
title = "Tissue-specific transformation by epidermal growth factor receptor: A single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential",
abstract = "Avian c-erbB is activated to a leukemia oncogene following truncation of its amino-terminal, ligand-binding domain by retroviral insertion. The insertionally activated transcripts encode protein products that have constitutive tyrosine kinase activity and that can induce erythroleukemia but not sarcomas. We have found that a single point mutation within the ATP-binding pocket of the tyrosine kinase domain in this truncated molecule can increase the ability of this oncogene to induce anchorage-independent growth of fibroblasts in vitro and fibrosarcoma formation in vivo. Associated with this increased transforming potential is a corresponding increase in the kinase activity of the mutant erbB protein product. The mutation, which converts a valine to isoleucine at position 157 of the insertionally activated c-erbB product, is at a residue that is highly conserved within the protein kinase family. To our knowledge, this is the first demonstration of a point mutation in the ATP-binding pocket that activates a tyrosine kinase.",
keywords = "cellular transformation, erythroblastosis, retrovirus, sarcoma, tyrosine kinase",
author = "Shu, {H. K.G.} and Pelley, {R. J.} and Kung, {H. J.}",
year = "1990",
month = "12",
day = "1",
doi = "10.1073/pnas.87.23.9103",
language = "English",
volume = "87",
pages = "9103--9107",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "23",

}

TY - JOUR

T1 - Tissue-specific transformation by epidermal growth factor receptor

T2 - A single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential

AU - Shu, H. K.G.

AU - Pelley, R. J.

AU - Kung, H. J.

PY - 1990/12/1

Y1 - 1990/12/1

N2 - Avian c-erbB is activated to a leukemia oncogene following truncation of its amino-terminal, ligand-binding domain by retroviral insertion. The insertionally activated transcripts encode protein products that have constitutive tyrosine kinase activity and that can induce erythroleukemia but not sarcomas. We have found that a single point mutation within the ATP-binding pocket of the tyrosine kinase domain in this truncated molecule can increase the ability of this oncogene to induce anchorage-independent growth of fibroblasts in vitro and fibrosarcoma formation in vivo. Associated with this increased transforming potential is a corresponding increase in the kinase activity of the mutant erbB protein product. The mutation, which converts a valine to isoleucine at position 157 of the insertionally activated c-erbB product, is at a residue that is highly conserved within the protein kinase family. To our knowledge, this is the first demonstration of a point mutation in the ATP-binding pocket that activates a tyrosine kinase.

AB - Avian c-erbB is activated to a leukemia oncogene following truncation of its amino-terminal, ligand-binding domain by retroviral insertion. The insertionally activated transcripts encode protein products that have constitutive tyrosine kinase activity and that can induce erythroleukemia but not sarcomas. We have found that a single point mutation within the ATP-binding pocket of the tyrosine kinase domain in this truncated molecule can increase the ability of this oncogene to induce anchorage-independent growth of fibroblasts in vitro and fibrosarcoma formation in vivo. Associated with this increased transforming potential is a corresponding increase in the kinase activity of the mutant erbB protein product. The mutation, which converts a valine to isoleucine at position 157 of the insertionally activated c-erbB product, is at a residue that is highly conserved within the protein kinase family. To our knowledge, this is the first demonstration of a point mutation in the ATP-binding pocket that activates a tyrosine kinase.

KW - cellular transformation

KW - erythroblastosis

KW - retrovirus

KW - sarcoma

KW - tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=0025602908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025602908&partnerID=8YFLogxK

U2 - 10.1073/pnas.87.23.9103

DO - 10.1073/pnas.87.23.9103

M3 - Article

VL - 87

SP - 9103

EP - 9107

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 23

ER -